-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to an observational study by Cedars-Sinai Medical Center, the majority of patients hospitalized with COVID-19 (coronavirus) pneumonia improved after receiving FDA-approved medication for rheumatoid arthritis.
had lower risk of inflammation, oxygen demand, blood pressure support, and death in patients with toluzumab compared to published reports of illness and death associated with COVID-19 severe illness. "Based on our preliminary results, I hope these drugs can help improve the condition in patients with COVID-19 pneumonia," Jordan said.
", but we couldn't know the results until a randomized controlled clinical trial was completed.
" this article from Bio Valley, for more information please download Bio Valley APP (